Data / Federal awards / NAICS 325412 / Department of Defense
Department of Defense contracts under NAICS 325412 Pharmaceutical Preparation Manufacturing: $270.4 million to 156 recipients (FY2024 to FY2027)
Updated October 6, 2026. Source: USAspending.gov.
Department of Defense obligated $270.4 million under NAICS 325412, Pharmaceutical Preparation Manufacturing, across 50,268 contract awards to 156 named recipients in fiscal years 2024 to 2027. The largest recipients are TEVA PHARMACEUTICALS USA, INC. ($109.7 million), CANADIAN COMMERCIAL CORPORATION ($71.9 million), CARDINAL HEALTH 414, LLC ($11.3 million). 13 opportunities under this code are open on SAM.gov now.
The request: Every federal contract awarded by Department of Defense under NAICS 325412, with the winner, the value and the period of performance. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- Agency
- Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Contract awards
- 50,268
- Obligated
- $270.4 million
- Named recipients
- 156
- Small business share of obligations
- 8%
- Full and open competition share
- 11%
- Set aside share
- 1%
- Latest action
- 2026-07-06
Open opportunities in this niche
The same code on SAM.gov, read each morning: 13 opportunities you can still respond to.
Incumbents at this agency
Ranked by dollars obligated in fiscal years 2024 to 2027.
| Recipient | Business size | Awards | Obligated | Share |
|---|---|---|---|---|
| TEVA PHARMACEUTICALS USA, INC. | Other Than Small Business | 181 | $109.7 million | 40.6% |
| CANADIAN COMMERCIAL CORPORATION | Other Than Small Business | 569 | $71.9 million | 26.6% |
| CARDINAL HEALTH 414, LLC | Other Than Small Business | 54 | $11.3 million | 4.2% |
| SIGA TECHNOLOGIES, INC. | Other Than Small Business | 2 | $10.1 million | 3.7% |
| ADVANCED ACCELERATOR APPLICATIONS USA INC | Other Than Small Business | 10 | $7.6 million | 2.8% |
| DMS PHARMACEUTICAL GROUP INC | Small Business | 22,755 | $7.1 million | 2.6% |
| CARDINAL HEALTH, INC. | Other Than Small Business | 16,523 | $5.1 million | 1.9% |
| NOVARTIS PHARMACEUTICALS CORPORATION | Other Than Small Business | 10 | $4.9 million | 1.8% |
| JUBILANT HOLLISTERSTIER LLC | Other Than Small Business | 1 | $3.1 million | 1.2% |
| LANTHEUS MEDICAL IMAGING, INC. | Small Business | 23 | $3 million | 1.1% |
| SOFIE CO. | Small Business | 32 | $2.9 million | 1.1% |
| BOSTON SCIENTIFIC CORP | Other Than Small Business | 16 | $2.7 million | 1.0% |
| AMERICAN REGENT INC | Other Than Small Business | 126 | $2.6 million | 0.9% |
| GENENTECH USA, INC | Other Than Small Business | 23 | $2.5 million | 0.9% |
| PFIZER INC | Other Than Small Business | 2,266 | $2.5 million | 0.9% |
| PETNET SOLUTIONS, INC. | Other Than Small Business | 18 | $2.3 million | 0.9% |
| KAPLAN INDUSTRIES, INC. | Small Business | 21 | $2.3 million | 0.9% |
| INO THERAPEUTICS LLC | Other Than Small Business | 15 | $1.9 million | 0.7% |
| BRACCO DIAGNOSTICS INC. | Other Than Small Business | 4 | $1.7 million | 0.6% |
| CEPHEID | Other Than Small Business | 1 | $1.7 million | 0.6% |
| CURIUM US LLC | Other Than Small Business | 9 | $1.6 million | 0.6% |
| GREER LABORATORIES, INC. | Other Than Small Business | 8 | $1.5 million | 0.6% |
| SZY HOLDINGS, LLC | Small Business | 2,964 | $1.3 million | 0.5% |
| MEDI-PHYSICS, INC. | Other Than Small Business | 13 | $1.1 million | 0.4% |
| HAMAMATSU/QUEEN'S PET IMAGING CENTER, LLC | Small Business | 1 | $980,580 | 0.4% |
| CENTRAL ADMIXTURE PHARMACY SERVICES, INC | Other Than Small Business | 12 | $847,778 | 0.3% |
| ANBEX INC | Small Business | 34 | $810,858 | 0.3% |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | Other Than Small Business | 7 | $743,535 | 0.3% |
| CHEROKEE NATION INTEGRATED HEALTH, L.L.C. | Other Than Small Business | 25 | $711,170 | 0.3% |
| RLS (USA) INC. | Small Business | 10 | $665,401 | 0.2% |
| SIRTEX MEDICAL INC | Other Than Small Business | 8 | $539,275 | 0.2% |
| FENWAL, INC. | Other Than Small Business | 100 | $475,513 | 0.2% |
| FAGRON COMPOUNDING SERVICES, LLC | Small Business | 13 | $394,096 | 0.1% |
| AL ITQAAN CONTRACTING MAINTENANCE AND TRADING EST | Other Than Small Business | 2 | $340,203 | 0.1% |
| TRILLAMED LLC | Small Business | 4 | $302,725 | 0.1% |
| PHARMALUCENCE, INC. | Other Than Small Business | 5 | $295,878 | 0.1% |
| 60 DEGREES PHARMACEUTICALS, INC. | Small Business | 2 | $282,896 | 0.1% |
| COVETRUS NORTH AMERICA, LLC | Other Than Small Business | 401 | $261,310 | 0.1% |
| SANOFI VACCINES US INC. | Other Than Small Business | 6 | $257,332 | 0.1% |
| SUMMIT SHOJI INC. | Other Than Small Business | 41 | $245,654 | 0.1% |
| GOLDEN STATE MEDICAL SUPPLY, INC. | Small Business | 530 | $237,018 | 0.1% |
| VALUE DRUG, LIMITED | Small Business | 1 | $235,650 | 0.1% |
| CERILLIANT CORPORATION | Other Than Small Business | 16 | $195,180 | 0.1% |
| AGILENT TECHNOLOGIES INC | Other Than Small Business | 1 | $177,264 | 0.1% |
| TRI-PHARMA, INC. | Small Business | 1 | $168,425 | 0.1% |
| WELLS PHARMA OF HOUSTON LLC | Small Business | 2 | $166,659 | 0.1% |
| JUBILANT DRAXIMAGE RADIOPHARMACIES, INC. | Small Business | 2 | $157,011 | 0.1% |
| GLAXOSMITHKLINE, LLC | Other Than Small Business | 4 | $150,187 | 0.1% |
| OAKRIDGE DYNAMICS LLC | Small Business | 23 | $137,490 | 0.1% |
| CERUS CORPORATION | Small Business | 1 | $132,400 | 0.0% |
Offices buying
| Sub agency | Awards | Obligated |
|---|---|---|
| Defense Logistics Agency | 49,865 | $201.4 million |
| Department of the Army | 203 | $48.4 million |
| Defense Health Agency | 183 | $19.1 million |
| Department of the Air Force | 12 | $1.2 million |
| U.S. Special Operations Command | 2 | $250,743 |
| Department of the Navy | 2 | $77,257 |
| Defense Contract Management Agency | 1 | $0 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $116.4 million |
| FY2025 | $89 million |
| FY2026 | $65 million |
Products and services bought
| Code | Product or service | Awards | Obligated |
|---|---|---|---|
| 6505 | Drugs and Biologicals | 49,055 | $251.5 million |
| 6515 | Medical and Surgical Instruments, Equipment, and Supplies | 331 | $7.6 million |
| 6550 | In Vitro Diagnostic Substances, Reagents, Test Kits and Sets | 274 | $4.2 million |
| 6640 | Laboratory Equipment and Supplies | 20 | $2.7 million |
| Q522 | Medical- Radiology | 1 | $1.2 million |
| Q517 | Pharmacy Services | 17 | $881,313 |
| 6509 | Drugs and Biologicals, Veterinary Use | 507 | $745,197 |
| AN41 | Health R&d Services; Health Care - Other; Basic Research | 1 | $311,862 |
Largest contract awards
| Award ID | Recipient | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| W911SR24C0030 | SIGA TECHNOLOGIES, INC. | Department of Defense | Definitive Contract | 325412 | PROCUREMENT OF 23,030 TPOXX ORAL COURSES AND 50 TPOXX IV COURSES. TO MAINTAIN NATIONAL STOCKPILE. | $8,999,677 | $8,999,677 | August 2, 2024 | December 31, 2024 | New York, NY | usaspending.gov |
| SPE2D624F834Q | CANADIAN COMMERCIAL CORPORATION | Department of Defense | Delivery Order | 325412 | 4562900082!RSDL | $8,009,118 | $8,009,118 | November 27, 2023 | July 17, 2024 | Canada | usaspending.gov |
| SPE2D624F2YLL | CANADIAN COMMERCIAL CORPORATION | Department of Defense | Delivery Order | 325412 | 4565958528!RSDL | $6,054,837 | $6,054,837 | September 27, 2024 | December 13, 2024 | Canada | usaspending.gov |
| SPE2D624F2PRW | CANADIAN COMMERCIAL CORPORATION | Department of Defense | Delivery Order | 325412 | 4565890814!RSDL | $5,731,983 | $5,731,983 | September 20, 2024 | December 6, 2024 | Canada | usaspending.gov |
| SPE2DP25F2789 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | Delivery Order | 325412 | 8511147946!ADENOVIRUS TYPE 4 A | $5,285,022 | $5,285,022 | January 28, 2025 | February 4, 2025 | Parsippany, NJ | usaspending.gov |
| SPE2D626F6F83 | CANADIAN COMMERCIAL CORPORATION | Department of Defense | Delivery Order | 325412 | 4571290114!REACTIVE SKIN DECONTAMINATION LOTION | $5,197,198 | $5,197,198 | March 26, 2026 | June 2, 2026 | Canada | usaspending.gov |
| SPE2DP26F1649 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | Delivery Order | 325412 | 8511856699!ADENOVIRUS TYPE 4 A | $3,950,554 | $3,950,554 | January 13, 2026 | January 27, 2026 | Parsippany, NJ | usaspending.gov |
| SPE2DP26F3586 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | Delivery Order | 325412 | 8511984334!ADENOVIRUS TYPE 4 A | $3,950,554 | $3,950,554 | March 18, 2026 | March 25, 2026 | Parsippany, NJ | usaspending.gov |
| SPE2DP26F2814 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | Delivery Order | 325412 | 8511918533!ADENOVIRUS TYPE 4 A | $3,950,554 | $3,950,554 | February 17, 2026 | February 24, 2026 | Parsippany, NJ | usaspending.gov |
| W81K0024F0177 | ADVANCED ACCELERATOR APPLICATIONS USA INC | Department of Defense | Delivery Order | 325412 | DELIVERY ORDER FOR PLUVICTO AND LUTATHERA | $3,363,558 | $3,363,558 | October 1, 2024 | September 30, 2025 | Jbsa Ft Sam Houston, TX | usaspending.gov |
| SPE2D625F0119 | CANADIAN COMMERCIAL CORPORATION | Department of Defense | Delivery Order | 325412 | 4566004748!RSDL | $3,233,834 | $3,233,834 | October 2, 2024 | December 18, 2024 | Canada | usaspending.gov |
| W81K0025FA195 | NOVARTIS PHARMACEUTICALS CORPORATION | Department of Defense | Delivery Order | 325412 | LUTATHERA AND PLUVICTO | $3,232,080 | $3,232,080 | October 1, 2025 | September 30, 2026 | San Antonio, TX | usaspending.gov |
| SPE2DP25F0856 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | Delivery Order | 325412 | 8511009796!ADENOVIRUS TYPE 4 A | $3,176,095 | $3,176,095 | November 14, 2024 | November 19, 2024 | Parsippany, NJ | usaspending.gov |
| W91YTZ23P0137 | JUBILANT HOLLISTERSTIER LLC | Department of Defense | Purchase Order | 325412 | VENOM IMMUNOTHERAPY SUPPLIES (BASE) | $3,144,308 | $3,144,308 | October 1, 2023 | September 30, 2027 | Fort George G Meade, MD | usaspending.gov |
| SPE2D626F11R8 | CANADIAN COMMERCIAL CORPORATION | Department of Defense | Delivery Order | 325412 | 4570252901!RSDL | $2,954,436 | $2,954,436 | December 11, 2025 | February 27, 2026 | Canada | usaspending.gov |
| W81K0023C0013 | ADVANCED ACCELERATOR APPLICATIONS USA INC | Department of Defense | Definitive Contract | 325412 | PLUVICTO (LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN) AND LUTATHERA (LUTETIUM LU-177 DOTATATE) | $2,570,634 | $2,570,634 | October 1, 2023 | September 30, 2024 | Millburn, NJ | usaspending.gov |
| SPE2D624F9R8L | CANADIAN COMMERCIAL CORPORATION | Department of Defense | Delivery Order | 325412 | 4564909465!RSDL | $2,505,207 | $2,505,207 | June 14, 2024 | August 29, 2024 | Canada | usaspending.gov |
| SPE2DP24F1238 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | Delivery Order | 325412 | 8510325537!ADENOVIRUS TYPE 4 A | $2,443,150 | $2,443,150 | December 14, 2023 | December 19, 2023 | Parsippany, NJ | usaspending.gov |
| SPE2D624F4ED9 | CANADIAN COMMERCIAL CORPORATION | Department of Defense | Delivery Order | 325412 | 4565236995!RSDL | $2,286,442 | $2,286,442 | July 17, 2024 | September 30, 2024 | Canada | usaspending.gov |
| SPE2D625F466Z | CANADIAN COMMERCIAL CORPORATION | Department of Defense | Delivery Order | 325412 | 4566355940!RSDL | $2,286,442 | $2,286,442 | November 5, 2024 | January 23, 2025 | Canada | usaspending.gov |
| SPE2D624F837Q | CANADIAN COMMERCIAL CORPORATION | Department of Defense | Delivery Order | 325412 | 4562930585!RSDL | $2,205,714 | $2,205,714 | November 27, 2023 | July 5, 2024 | Canada | usaspending.gov |
| SPE2D624F0H98 | CANADIAN COMMERCIAL CORPORATION | Department of Defense | Delivery Order | 325412 | 4563982426!RSDL | $2,159,418 | $2,159,418 | March 13, 2024 | May 24, 2024 | Canada | usaspending.gov |
| SPE2DP26F0979 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | Delivery Order | 325412 | 8511784063!ADENOVIRUS TYPE 4 A | $1,981,883 | $1,981,883 | December 1, 2025 | December 9, 2025 | Parsippany, NJ | usaspending.gov |
| SPE2D025F0681 | AMERICAN REGENT INC | Department of Defense | Delivery Order | 325412 | 8511647514!OTHER MEDICAL | $1,777,033 | $1,777,033 | September 22, 2025 | October 27, 2025 | Shirley, NY | usaspending.gov |
| SPE2D624F3945 | CANADIAN COMMERCIAL CORPORATION | Department of Defense | Delivery Order | 325412 | 4562498612!RSDL | $1,704,570 | $1,704,570 | October 17, 2023 | January 3, 2024 | Canada | usaspending.gov |
Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.